Corpus Intelligence IC Memo — AVERA SACRED HEART HOSPITAL 2026-04-26 09:57 UTC
IC Memo — AVERA SACRED HEART HOSPITAL
Investment Committee Memorandum | SD | 42 beds | Grade B | EBITDA uplift $9.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

AVERA SACRED HEART HOSPITAL

CCN 430012 | YANKTON, SD | 42 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

AVERA SACRED HEART HOSPITAL is a 42-bed suburban community hospital in YANKTON, SD with $123.1M in net patient revenue and a -1.9% operating margin. The hospital serves a payer mix of 41.6% Medicare, 8.9% Medicaid, and 49.4% commercial.

Thesis: Turnaround. Our ML models identify $9.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -1.9% to 5.4% (+736bps).

Net Revenue HCRIS$123.1M
Current EBITDA COMPUTED$-2.4M
Operating Margin COMPUTED-1.9%
Occupancy HCRIS70.3%
Revenue / Bed COMPUTED$2.9M
Net-to-Gross HCRIS33.6%
Distress Probability ML42.9%

2. Market Context & Competitive Position

63
SD Hospitals
-3.2%
State Median Margin
34
Comparable Hospitals

SD has 63 Medicare-certified hospitals with a median operating margin of -3.2%. The target's margin of -1.9% places it above the state median. Among 34 size-comparable peers (21-84 beds), the median margin is -2.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (21-84), prioritizing same-state peers. 34 hospitals in the comp set.

HospitalStateBedsRevenueMargin
AVERA SACRED HEART HOSPITAL (Target)SD42$123.1M-1.9%
AVERA ST. LUKESSD50$210.6M-7.3%
AVERA HEART HOSPITAL OF SOUTH SD53$139.0M1.5%
SIOUX FALLS SPECIALTY HOSPITALSD33$138.8M31.7%
AVERA QUEEN OF PEACESD50$129.2M-8.7%
PRAIRIE LAKES HEALTH CARE CENTSD69$123.9M-9.8%
AVERA QUEEN OF PEACESD25$122.9M-5.8%
MONUMENT HEALTH SPEARFISH HOSPSD27$116.6M1.9%
SIOUXLAND SURGERY CENTERSD38$105.7M40.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $9.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.6M+210bp18mo
Cost to Collect4.5%2.5%$2.5M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.4M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.5M+122bp9mo
Clean Claim Rate88.0%96.0%$79K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.6M
Cost to Collect
$2.5M
Denial Rate Reduction
$2.4M
A/R Days Reduction
$1.5M
Clean Claim Rate
$79K
Total EBITDA Uplift$9.1M
Current EBITDA$-2.4M
+ RCM Uplift+$9.1M
Pro Forma EBITDA$6.7M
Current Margin-1.9%
Pro Forma Margin5.4%
WC Released (1x)$4.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-3.7M$74.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-3.7M$81.2M0.00x-100.0%
Bull Case9.0x11.0x$-3.3M$109.9M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-3.3M$118.9M0.00x-100.0%
Bear Case11.0x10.0x$-4.0M$30.7M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-4.0M$32.5M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 34 hospitals with 21-84 beds
  • Same-state prioritization (n=35)
  • Comp margins: P25=-7.5% / P50=-2.4% / P75=9.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.